HOME >> MEDICINE >> NEWS
Prostate cancer therapy - study suggests new molecular screening theory

(Uppsala, April 15th) -- Levels of the Smad7 protein may predict therapeutic response in patients with prostate cancer according to research published today by investigators at the Uppsala Branch of the Ludwig Institute for Cancer Research (LICR).

"Although the 2-ME compound is in early clinical trials, no-one has fully understood the molecular mechanisms of how it causes the death of cancer cells, but not normal cells," says Dr. Marne Landstrm, the senior author of the paper published in the prestigious Journal of Biological Chemistry. "We found that 2-ME works through a protein called Smad7, and that artificially lowering the amount of Smad7 in prostate cancer cells reduced 2-ME's ability to cause cell death. This finding suggests that the levels of Smad7, and other proteins in this molecular pathway, might predict the cell-killing ability of other cancer therapeutics and thus their effectiveness for treating individual patients."

Smad7 was originally discovered at the LICR Uppsala Branch in 1997, and the team reported, in the journal Nature, that the protein stopped cell growth by inhibiting a crucial oncogene known as TGF beta. As a result of the current study, Smad7 is now thought to play a crucial role connecting the mechanisms of cell growth, governed by TGF beta, and those of cell death, governed by another oncogene, p38 MAPK.

Dr. Carl-Henrik Heldin, Director of both the Uppsala Branch and LICR's international 'TGF beta Program' cautions that the research is at a preliminary stage and that more work is now needed to investigate whether the levels of Smad7 correlate with patients' responses to different therapies. "If we can determine which patients are most likely to benefit from a particular therapeutic approach, we can reduce the possibility that a patient will undergo treatment that has side-effects but no benefit. More importantly, we may one day be able to effectively target each individual patient with the therapy-type best fo
'"/>

Contact: Sarah L. White, Ph.D.
swhite@licr.org
1-212-450-1543
Ludwig Institute for Cancer Research
14-Apr-2005


Page: 1 2

Related medicine news :

1. Prostate cancer patients see high survival rates with seed implants
2. Prostate cancer treatment increases risk of diabetes and heart disease
3. Prostate cancer research may be faster with PSA endpoints
4. Prostate treatment decisions based on perception more than fact
5. Prostate cancer test affected by demographic and lifestyle factors
6. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
7. Survival differences by race most apparent in advanced stages of breast cancer
8. Stomach cancer rate set to fall further 25 percent over next decade
9. MRI finds breast cancer before it becomes dangerous
10. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
11. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/2/2018)... (PRWEB) , ... August 02, 2018 , ... Dr. ... psychology and brain biology of why some people could care less, demonstrating a “whatever” ... While there are many reasons for this, one often overlooked reason relates to being ...
(Date:8/2/2018)... ... August 02, 2018 , ... ... recruit caregivers to participate in brain cancer caregiver and patient clinical trials at ... Health Services of Southern California. , At the Pacific Neuroscience Institute ...
(Date:8/2/2018)... (PRWEB) , ... August 02, ... ... national medical claims management solutions provider, announced today that it has acquired ... evaluations (IMEs), medical record reviews, peer reviews, and related services. , Medlogix ...
(Date:8/2/2018)... (PRWEB) , ... August 02, 2018 , ... Josh Sprague, ... hydration products for high-intensity athletes, recently sat down with SGB Media to discuss his ... a simple philosophy. His goal was to create better, more efficient gear to help ...
(Date:8/1/2018)... ... August 01, 2018 , ... Matt ... and Vice President, Addiction Treatment Services, Behavioral Health Division of Universal ... Services business of Universal Health Services, which includes the FRN portfolio comprised of ...
Breaking Medicine News(10 mins):
(Date:8/2/2018)... ... ... What: The Wharton School is pleased to invite business journalists to apply ... who cover aspects of public policy to attend the Wharton Seminars for Business ... cost of tuition, course materials, most group meals, lodging for three nights and airfare ...
(Date:8/2/2018)... ... August 02, 2018 , ... Periodontist, Dr. Andres Sanchez, welcomes ... lengthening treatment at his Eden Prairie, MN practice. Aesthetic crown lengthening or ... decades of experience, Dr. Sanchez is excited to welcome new patients for a ...
(Date:8/2/2018)... ... August 02, 2018 , ... Clay and Associates DDS, PLC is excited ... Wallingford will join Dr. John Clay and Dr. Shaun O’Neill as an associate dentist ... for all of their patients' dental hygiene, encapsulates the core values of the professional ...
Breaking Medicine Technology:
Cached News: